lashondaarmytage

The Big Fat Weight Problems Market Although an FDA sub-panel suggested Contrave for authorization as an anti-obesity treatment, the FDA inevitably denied Contrave for anti-obesity treatment, and asked for a huge cardiovascular danger test to resolve possible adverse effects before it could approve the medication (Orexigen, 2011). Orexigen intends to appeal the decision after falling […]